Fluciclovine F18

Fluciclovine F18

SCHEMBL12824573

N[C@]1(C(=O)O)C[C@H](F)C1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluciclovine F18 SCHEMBL10017245 1.00 — —
Fluciclovine F18 SCHEMBL11939900 1.00 — —
Fluciclovine SCHEMBL5934962 1.00 — —
Fluciclovine F18 SCHEMBL11939897 1.00 — —
Fluciclovine F18 SCHEMBL1449765 1.00 — —
SCHEMBL25492080 0.84 GRM4 (0.58) —
SCHEMBL25492075 0.84 GRM4 (0.58) —
SCHEMBL23833793 0.84 GRM4 (0.58) —
SCHEMBL25492047 0.84 GRM4 (0.58) —
SCHEMBL30198807 0.84 GRM4 (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11077216-B2 Formulation and method of synthesis GE HEALTHCARE LIMITED (GB) 2021-08-03 — — US disclosed
US-9999692-B2 Radiolabelling process GE HEALTHCARE LIMITED (GB) 2018-06-19 — — US disclosed
US-7910745-B2 Organic compound and method for producing radioactive halogen-labeled organic compound using the same NIHON MEDI-PHYSICS CO., LTD. (JP) 2011-03-22 — — US disclosed
US-20090105489-A1 NOVEL ORGANIC COMPOUND AND METHOD FOR PRODUCING RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND USING THE SAME NIHON MEDI-PHYSICS CO. LTD. (JP) 2009-04-23 — — US disclosed
EP-1889834-A1 NOVEL ORGANIC COMPOUND AND METHOD FOR PRODUCING RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND USING THE SAME Nihon Medi-Physics Co., Ltd. (JP) 2008-02-20 — — EP disclosed
Send feedback